Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Mymd Pharmaceuticals Inc
(NQ:
MYMD
)
2.020
+0.020 (+1.00%)
Streaming Delayed Price
Updated: 9:46 AM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Mymd Pharmaceuticals Inc
< Previous
1
2
3
4
5
6
Next >
12 Health Care Stocks Moving In Friday's After-Market Session
November 24, 2023
Via
Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
November 23, 2023
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
November 22, 2023
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
October 24, 2023
Via
Benzinga
Five Hours Of Pain Relief? Preclinical Study Shows Promising Results With This Non-Toxic CBD
October 19, 2023
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced on Thursday the results from a preclinical study of its investigational cannabinoid Supera-CBD, a novel, synthetic, non-toxic cannabidiol (CBD)...
Via
Benzinga
MyMD Announces Preclinical Study Results Showing Novel Cannabidiol Analog, Supera-CBD™, Reduced Acute Inflammatory Pain
October 19, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals to Present Updated Statistically Significant Phase 2 Data for MYMD-1, Potential TNF-α Market Disrupter, at BioFuture 2023
October 04, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
More Personal Portfolio: Biotech, Commodities, And Gold
September 24, 2023
In a few years we will know if that was an extraordinarily opportunistic moment, or a long and frustrating rabbit hole.
Via
Talk Markets
MyMD Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
August 25, 2023
The Dow Jones closed lower by over 1% on Thursday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in...
Via
Benzinga
Topics
Stocks
Exposures
US Equities
FDA Accepts MyMD Pharmaceuticals’ Investigational New Drug Application (IND) for Phase 2 Study of oral TNF-α inhibitor MYMD-1® in Rheumatoid Arthritis (RA)
August 14, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Intraday Session
August 11, 2023
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
August 07, 2023
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth reading about on Monday morning!
Via
InvestorPlace
MyMD Pharmaceuticals to Hold Conference Call Today to Discuss Phase 2 Trial Results
August 02, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
August 01, 2023
It's time for a look at the biggest pre-market stock movers as we check out the latest news worth reading on Tuesday morning!
Via
InvestorPlace
Why Is MyMD Pharmaceuticals Stock Gaining Today?
July 31, 2023
MyMD Pharmaceuticals Inc (NASDAQ: MYMD) announced topline results from its randomized Phase 2 study of oral TNF-α inhibitor, MYMD-1, in patients with chronic inflammation associated with
Via
Benzinga
MyMD Pharmaceuticals Reports Statistically Significant Positive Topline Phase 2 Results for Next Generation Oral TNF-α Inhibitor MYMD-1® in Sarcopenia/Age-Related Frailty
July 31, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
July 31, 2023
It's time to start off the week with a breakdown of the biggest pre-market stock movers worth watching for Monday morning!
Via
InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
July 27, 2023
Via
Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
July 10, 2023
Via
Benzinga
Why Caribou Biosciences Shares Are Trading Higher By Around 58%? Here Are Other Stocks Moving In Thursday's Session
July 06, 2023
Gainers Caribou Biosciences, Inc. (NASDAQ: CRBU) shares jumped 58.1% to $6.45 after the company announced a $25 million equity investment from Pfizer.
Via
Benzinga
Why Icahn Enterprises Shares Are Trading Higher By 18%? Here Are Other Stocks Moving In Monday's Mid-Day Session
July 10, 2023
Gainers Mobilicom Limited (NASDAQ: MOB) shares jumped 81.3% to $2.7187 after the company announced it received a commercial scale purchase order from Teledyne-FLIR for the production of drones for the...
Via
Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
May 30, 2023
Via
Benzinga
MyMD Pharmaceuticals® Provides Dosing Update on Phase 2 Multi-Center Clinical Trial of MYMD-1® as a Therapy for Delaying Aging and Extending Healthy Lifespan
April 12, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
MyMD Pharmaceuticals® and Charles River Present Positive Data for Next Generation, Oral TNF-α Inhibitor MYMD-1® in Rheumatoid Arthritis
March 20, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's Pre-Market Session
March 10, 2023
Via
Benzinga
MyMD Joins LOT Network To Protect Company And Shareholders From Patent Trolls
March 08, 2023
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) has joined LOT Network, the international, non-profit community of companies working together to protect themselves against litigation brought on by patent...
Via
Benzinga
MyMD Joins LOT Network in Effort to Protect Company and Shareholders from Patent Trolls
March 08, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
12 Health Care Stocks Moving In Friday's After-Market Session
March 03, 2023
Via
Benzinga
DEA Concludes MyMD's Supera-CBD Is Not A Controlled Substance Or Listed Chemical
March 02, 2023
MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD) announced that the U.S. Drug Enforcement Administration has conducted a scientific review and determined that investigational cannabinoid Supera-CBD is not...
Via
Benzinga
MyMD Announces U.S. Drug Enforcement Administration (DEA) Determines Supera-CBD™ is not a Controlled Substance or Listed Chemical
March 02, 2023
From
MyMD Pharmaceuticals, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.